News – Okami Medical – Okami Medical

Skip to content

LOBO Technology
Clinical Experience
News
About
Contact

LOBO Technology
Clinical Experience
News
About
Contact

Latest from Okami

Okami Medical Appoints Rhonda Robb As President And Chief Executive Officer

January 8, 2024

Okami Medical Appoints Rhonda Robb As President And Chief Executive Officer Read More »

Okami Medical Announces FDA 510(k) Clearance of the LOBO-7 and LOBO-9 Vascular Occluders To Address A Wide Range Of Peripheral Embolization Cases

June 7, 2022

Okami Medical Announces FDA 510(k) Clearance of the LOBO-7 and LOBO-9 Vascular Occluders To Address A Wide Range Of Peripheral Embolization Cases Read More »

Okami Medical Announces FDA 510(k) Clearance of the LOBO-5 Vascular Occluder

December 16, 2020

Okami Medical Announces FDA 510(k) Clearance of the LOBO-5 Vascular Occluder Read More »

Okami Medical Announces Closing Of $7.2M Series D Financing

June 24, 2020

Okami Medical Announces Closing Of $7.2M Series D Financing Read More »

Okami Medical Announces First Patients Treated With The LOBO Vascular Occluder

March 5, 2020

Okami Medical Announces First Patients Treated With The LOBO Vascular Occluder Read More »

Okami Medical Announces Major Milestones: FDA 510(k) Clearance and Key Patent for the LOBO Vascular Occluder

November 4, 2019

Okami Medical Announces Major Milestones: FDA 510(k) Clearance and Key Patent for the LOBO Vascular Occluder Read More »

Post pagination

8 Argonaut, Suite 100
Aliso Viejo, CA 92656
info@okamimedical.com
949-446-9710

Okami Medical and LOBO are registered trademarks of Okami Medical, Inc., SENDERO is a trademark of Okami Medical, Inc., HDBRAID is a registered trademark of Inceptus Medical LLC. in the United States and other countries. Copyright © 2024 Okami Medical. All rights reserved.

Linkedin X-twitter

Scroll to Top